James D. Bearden - Concepedia

Author

James D. Bearden

Also Known As

J D Bearden, J. Bearden, J. D. Bearden, J.D. Bearden, JAMES BEARDEN, James Bearden, James D Bearden, James D. Bearden, James D. Bearden III, James Dewitt Bearden

129

Publications

7.5K

Citations

H-Index

107

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona University of South Carolina Upstate National Cancer Institute Spartanburg Regional Healthcare System

About

James D. Bearden is an author at Mayo Clinic specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	1.2K
2	Health Sciences	5	5	424
3	Nursing	2	2	51
4	Arts	1	1	26
5	Business	1	1	55

James D. Bearden

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, JAMA	2008	2.1K
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell, JAMA Oncology	2015	979
Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 David R. Gandara, Kari Chansky, Kathy S. Albain, Journal of Clinical Oncology	2003	372
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey, Blood	2000	263
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA Debra L. Barton, Edward J. Wos, Rui Qin, Supportive Care in Cancer Ncctg Trial N06caHealth SciencesPeripheral Nerve InjuryPain MedicineNeuropathic Pain	2010	248
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma John D. Hainsworth, Howard A. Burris, Lisa H. Morrissey, Blood	2000	248
Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07 Stephanie R. Land, Jacek A Kopec, Reena S. Cecchini, Journal of Clinical Oncology	2007	237
Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study. Charles W. Taylor, S Green, William S. Dalton, Journal of Clinical Oncology	1998	208
Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4 Robert C. Miller, David J. Schwartz, Jeff A. Sloan, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineOncologyRadiation TherapyMometasone Furoate EffectMedicine	2010	167
Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26 Roy E. Smith, Ann Brown, Eleftherios P. Mamounas, Journal of Clinical Oncology	1999	155

Page 1